Literature DB >> 22565298

The pathophysiology and clinical presentation of cerebral amyloid angiopathy.

Eitan Auriel1, Steven Mark Greenberg.   

Abstract

Cerebral amyloid angiopathy (CAA) is defined as the deposition of amyloid ß peptide within leptomeningial and cortical vessels, likely reflecting an imbalance between Aβ production and clearance. Amyloid buildup triggers a series of destructive alterations in the cerebral vascular architecture, leading to a spectrum of neurological events including lobar intracerebral hemorrhage, brain ischemia and cognitive decline. Although traditionally diagnosed pathologically, neuroimaging has taken a central role in defining CAA. This review will discuss the pathological, clinical and radiological aspects of CAA.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565298     DOI: 10.1007/s11883-012-0254-z

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  85 in total

1.  Anti-Aβ autoantibodies in the CSF of a patient with CAA-related inflammation: a case report.

Authors:  J C DiFrancesco; M Brioschi; L Brighina; C Ruffmann; E Saracchi; G Costantino; G Galimberti; E Conti; N A Curtò; L Marzorati; P Remida; F Tagliavini; M Savoiardo; C Ferrarese
Journal:  Neurology       Date:  2011-03-01       Impact factor: 9.910

2.  Detection of cerebral microbleeds with quantitative susceptibility mapping in the ArcAbeta mouse model of cerebral amyloidosis.

Authors:  Jan Klohs; Andreas Deistung; Ferdinand Schweser; Joanes Grandjean; Marco Dominietto; Conny Waschkies; Roger M Nitsch; Irene Knuesel; Jürgen R Reichenbach; Markus Rudin
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-17       Impact factor: 6.200

3.  Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan.

Authors:  J Masuda; K Tanaka; K Ueda; T Omae
Journal:  Stroke       Date:  1988-02       Impact factor: 7.914

Review 4.  Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.

Authors:  Leonardo Pantoni
Journal:  Lancet Neurol       Date:  2010-07       Impact factor: 44.182

5.  Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles.

Authors:  R Natté; M L Maat-Schieman; J Haan; M Bornebroek; R A Roos; S G van Duinen
Journal:  Ann Neurol       Date:  2001-12       Impact factor: 10.422

Review 6.  Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.

Authors:  Martin C Herzig; William E Van Nostrand; Mathias Jucker
Journal:  Brain Pathol       Date:  2006-01       Impact factor: 6.508

Review 7.  Steroid responsive encephalopathy in cerebral amyloid angiopathy: a case report and review of evidence for immunosuppressive treatment.

Authors:  Raoul P Kloppenborg; Edo Richard; Marieke E S Sprengers; Dirk Troost; Piet Eikelenboom; Paul J Nederkoorn
Journal:  J Neuroinflammation       Date:  2010-03-09       Impact factor: 8.322

8.  Course of cerebral amyloid angiopathy-related inflammation.

Authors:  C Kinnecom; M H Lev; L Wendell; E E Smith; J Rosand; M P Frosch; S M Greenberg
Journal:  Neurology       Date:  2007-04-24       Impact factor: 9.910

9.  Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes.

Authors:  H V Vinters; J J Gilbert
Journal:  Stroke       Date:  1983 Nov-Dec       Impact factor: 7.914

Review 10.  Brain parenchymal and microvascular amyloid in Alzheimer's disease.

Authors:  H V Vinters; Z Z Wang; D L Secor
Journal:  Brain Pathol       Date:  1996-04       Impact factor: 6.508

View more
  32 in total

Review 1.  Amyloidosis associated with cerebral amyloid angiopathy: cell signaling pathways elicited in cerebral endothelial cells.

Authors:  Jorge Ghiso; Silvia Fossati; Agueda Rostagno
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy.

Authors:  Octavio M Pontes-Neto; Eitan Auriel; Steven M Greenberg
Journal:  Eur Neurol Rev       Date:  2012

Review 3.  Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.

Authors:  Antoine Louveau; Benjamin A Plog; Salli Antila; Kari Alitalo; Maiken Nedergaard; Jonathan Kipnis
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

Review 4.  [Cerebral amyloid angiopathy associated with inflammation].

Authors:  J Schaumberg; M Trauscheid; B Eckert; D Petersen; W Schulz-Schaeffer; J Röther; W Heide
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

Review 5.  Cerebral Amyloid Angiopathy, Alzheimer's Disease and MicroRNA: miRNA as Diagnostic Biomarkers and Potential Therapeutic Targets.

Authors:  J Weldon Furr; Diego Morales-Scheihing; Bharti Manwani; Juneyoung Lee; Louise D McCullough
Journal:  Neuromolecular Med       Date:  2019-10-04       Impact factor: 3.843

6.  Cerebral amyloid angiopathy in an aged sooty mangabey (Cercocebus atys).

Authors:  Olivia M D'Angelo; Jeromy Dooyema; Cynthia Courtney; Lary C Walker; Eric Heuer
Journal:  Comp Med       Date:  2013       Impact factor: 0.982

7.  Innate immunity receptor CD36 promotes cerebral amyloid angiopathy.

Authors:  Laibaik Park; Joan Zhou; Ping Zhou; Rose Pistick; Sleiman El Jamal; Linda Younkin; Joseph Pierce; Andrea Arreguin; Josef Anrather; Steven G Younkin; George A Carlson; Bruce S McEwen; Costantino Iadecola
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-04       Impact factor: 11.205

Review 8.  [Cerebral amyloid angiopathy and dementia].

Authors:  P Berlit; K Keyvani; M Krämer; R Weber
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

9.  Brain and circulating levels of Aβ1-40 differentially contribute to vasomotor dysfunction in the mouse brain.

Authors:  Laibaik Park; Ping Zhou; Kenzo Koizumi; Sleiman El Jamal; Mary Lou Previti; William E Van Nostrand; George Carlson; Costantino Iadecola
Journal:  Stroke       Date:  2012-11-29       Impact factor: 7.914

10.  A Novel Transgenic Rat Model of Robust Cerebral Microvascular Amyloid with Prominent Vasculopathy.

Authors:  Judianne Davis; Feng Xu; Joshua Hatfield; Hedok Lee; Michael D Hoos; Dominique Popescu; Elliot Crooks; Regina Kim; Steven O Smith; John K Robinson; Helene Benveniste; William E Van Nostrand
Journal:  Am J Pathol       Date:  2018-11-13       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.